Status:
COMPLETED
Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
Lead Sponsor:
Centenario Hospital Miguel Hidalgo
Conditions:
COVID-19
Eligibility:
All Genders
16-90 years
Phase:
PHASE3
Brief Summary
Background: In December 2019, patients with pneumonia secondary to a new subtype of Coronavirus (COVID-19) were identified in China. In a few weeks the virus spread and cases started practically all o...
Detailed Description
Background In late December 2019, the health authorities of the People's Republic of China reported several cases of pneumonia of unknown origin in Wuhan City, Hubei Province, China. On December 31, 2...
Eligibility Criteria
Inclusion
- RT-qPCR SARS-CoV-2 positivity or chest computed Tomography with suspected COVID-19 pneumonia
- Hospitalization by medical emergency staff criteria
Exclusion
- Other confirmed viral active and acute infection
Key Trial Info
Start Date :
May 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2020
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04391127
Start Date
May 4 2020
End Date
November 6 2020
Last Update
November 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jose Manuel Arreola Guerra
Aguascalientes, Mexico, 20259